Shioko Kimura is a Japanese-American biochemist specialized in endocrinology and the physiology and pathogenesis of diseases including thyroid and lung cancers. She heads the endocrinology section in the laboratory of metabolism at the National Cancer Institute.
Shioko Kimura | |
|---|---|
 Kimura in 2016 | |
| Nationality | Japanese |
| Citizenship | United States |
| Alma mater | Hokkaido University (PhD) |
| Scientific career | |
| Fields | Biochemistry, endocrinology, cancer research |
| Institutions | National Cancer Institute |
Early life and education
editKimura completed a Ph.D. in chemistry at Hokkaido University. She was a postdoctoral researcher at Queen's University at Kingston and a visiting fellow at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).[1]
Career
edit
At the National Cancer Institute (NCI), she started in the laboratory of molecular carcinogenesis. Since 1996, she heads the endocrinology section in the laboratory of metabolism.[1]
Kimura's research focuses on understanding the role of homeodomain transcription factor NKX2-1, a marker for lung adenocarcinoma in humans, and its downstream target, a novel cytokine, SCGB3A2 in development, homeostasis, physiology, and pathogenesis of diseases, particularly cancers of the thyroid and lung. Kimura uses cell culture and mouse models, and various genetically engineered mouse lines to investigate these problems. Her studies have suggested that SCGB3A2 has anti-cancer activity, and her group is currently extensively involved in uncovering the mechanism.[2]
Publications
edit- Yokoyama S, Cai Y, Murata M, Tomita T, Yoneda M, Xu L, Pilon AL, Cachau RE, Kimura S. "A novel pathway of LPS uptake through syndecan-1 leading to pyroptotic cell death". Elife. 2018 Dec 7;7:e37854. doi:10.7554/eLife.37854. PMID 30526845; PMC 6286126.
- Iwadate M, Takizawa Y, Shirai YT, Kimura S. "An in vivo model for thyroid regeneration and folliculogenesis". Lab Invest. 2018 Sep;98(9):1126-1132. doi:10.1038/s41374-018-0068-x. Epub 2018 Jun 26. PMID 29946134; PMC 6138525.
- Kido T, Yoneda M, Cai Y, Matsubara T, Ward JM, Kimura S. "Secretoglobin superfamily protein SCGB3A2 deficiency potentiates ovalbumin-induced allergic pulmonary inflammation." Mediators Inflamm. 2014;2014:216465. doi:10.1155/2014/216465. Epub 2014 Aug 27. PMID 25242865; PMC 4163287.
- Cai Y, Winn ME, Zehmer JK, Gillette WK, Lubkowski JT, Pilon AL, Kimura S. "Preclinical evaluation of human secretoglobin 3A2 in mouse models of lung development and fibrosis." Am J Physiol Lung Cell Mol Physiol. 2014 Jan 1;306(1):L10-22. doi:10.1152/ajplung.00037.2013. Epub 2013 Nov 8. PMID 24213919; PMC 3920213.
- Snyder, Eric L ; Watanabe, Hideo ; Magendantz, Margaret ; Hoersch, Sebastian ; Kimura, Shioko. "Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma". Mol Cell, 2013 Apr 25;50(2):185-99. doi:10.1016/j.molcel.2013.02.018. Epub 2013 Mar 21. PMID 23523371; PMC 3721642
References
edit- ^ a b "Shioko Kimura, Ph.D." Center for Cancer Research. 2014-08-12. Retrieved 2020-10-06.
This article incorporates text from this source, which is in the public domain.
- ^ "Principal Investigators". NIH Intramural Research Program. Retrieved 2020-10-06. This article incorporates text from this source, which is in the public domain.
This article incorporates public domain material from websites or documents of the National Institutes of Health.